Avid Bioservices Dividend
Dividend criteria checks 0/6
Avid Bioservices does not have a record of paying a dividend.
Key information
n/a
Dividend yield
n/a
Payout ratio
| Industry average yield | 2.9% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Earnings per share | -US$0.28 |
| Dividend yield forecast in 3Y | n/a |
Recent dividend updates
No updates
Recent updates
There's No Escaping Avid Bioservices, Inc.'s (NASDAQ:CDMO) Muted Revenues Despite A 40% Share Price Rise
Mar 07
We Think Avid Bioservices (NASDAQ:CDMO) Has A Fair Chunk Of Debt
Feb 28There's No Escaping Avid Bioservices, Inc.'s (NASDAQ:CDMO) Muted Revenues Despite A 39% Share Price Rise
Dec 28Does Avid Bioservices (NASDAQ:CDMO) Have A Healthy Balance Sheet?
Nov 10Calculating The Intrinsic Value Of Avid Bioservices, Inc. (NASDAQ:CDMO)
Oct 15Time To Worry? Analysts Are Downgrading Their Avid Bioservices, Inc. (NASDAQ:CDMO) Outlook
Jun 23Is Avid Bioservices (NASDAQ:CDMO) Using Too Much Debt?
Jun 12Little Excitement Around Avid Bioservices, Inc.'s (NASDAQ:CDMO) Earnings As Shares Take 26% Pounding
May 21Are Investors Undervaluing Avid Bioservices, Inc. (NASDAQ:CDMO) By 49%?
May 12Does Avid Bioservices (NASDAQ:CDMO) Have A Healthy Balance Sheet?
Mar 13Here's Why Avid Bioservices (NASDAQ:CDMO) Has A Meaningful Debt Burden
Nov 10Avid Bioservices GAAP EPS of $0.02 beats by $0.01, revenue of $36.7M beats by $3.26M
Sep 06Laughing Water Capital - Avid Bioservices: Not A Binary Bet But A Real Business
Jul 27Avid Bioservices GAAP EPS of $1.65 beats by $1.65, revenue of $31M beats by $2.04M
Jun 29Avid Bioservices (NASDAQ:CDMO) Seems To Use Debt Quite Sensibly
May 30Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if CDMO's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if CDMO's dividend payments have been increasing.
Dividend Yield vs Market
| Avid Bioservices Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (CDMO) | n/a |
| Market Bottom 25% (US) | 1.5% |
| Market Top 25% (US) | 4.7% |
| Industry Average (Biotechs) | 2.9% |
| Analyst forecast in 3 Years (CDMO) | n/a |
Notable Dividend: Unable to evaluate CDMO's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate CDMO's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate CDMO's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as CDMO has not reported any payouts.